Here are five recent updates on gastroenterology and endoscopy companies.
Boston Scientific director Ernest Mario sold 10,000 shares of company stock at an average of $12.96 per share. The total transaction value was $129,600, according to a WKRB News & Analysis report.
Carnegie Hill Endoscopy in New York will hold an open house to Can gastroenterologists create a sustainable future in uncertain times?FUSE endoscopy technology from EndoChoice.
CMS issued its final payment decision for Exact Sciences’ FDA-approved noninvasive stool DNA colorectal cancer screening test Cologuard. CMS will reimburse providers $502 per test.
The FDA granted the Aer-O-Scope Colonoscope System from GI View 510(k) clearance.
Sanovas, a company focused on the development of minimally invasive diagnostics, has received recognition from Frost & Sullivan for its MicroCam Technology Platform. Sanovas will accept the "New Product Innovation Leadership in Endoscopic Imaging" award on Dec. 2 in Toronto, Canada.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.